CFTR haplotypes in northern Iranian population
Vahid Kholghi Oskooei1, Mohammad Reza Esmaeili Dooki, Reza Tabaripour
1Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran.
Gene
|October 10, 2012
Summary
Genetic markers can improve carrier detection and prenatal diagnosis for cystic fibrosis (CF) in Iranian families. Analyzing specific polymorphisms aids in identifying CF-associated mutations and predicting disease in the heterogeneous Iranian population.
Area of Science:
- Medical Genetics
- Molecular Diagnostics
- Population Genetics
Background:
- Cystic fibrosis (CF) is an autosomal recessive disorder caused by CFTR mutations, presenting genetic heterogeneity in Iran.
- Direct mutation identification for CF diagnosis is challenging in the Iranian population.
- Polymorphic intragenic markers can aid in gene tracking for prenatal diagnosis and identifying mutation associations.
Purpose of the Study:
- To investigate the allelic distribution of specific genetic markers in Iranian CF patients and normal individuals.
- To assess the utility of these markers for carrier detection and prenatal diagnosis of CF in Iran.
Main Methods:
- Analysis of F508del mutation and polymorphisms (c.1210-12T(5_9), c.1408A>G, c.744-33GATT(6_8)) in 60 CF patients and 53 healthy controls from North Iran.
- Gene tracking and haplotype analysis.
Main Results:
- The c.1210-12T[7] allele was most prevalent in both normal individuals (87.7%) and non-F508del CF patients (86.7%).
- Allele frequencies for c.1408A>G were nearly equal in non-F508del CF patients and normal individuals.
- The c.744-33GATT(6_8) 7-repeat allele was most common in normal (80.2%) and non-F508del CF patients (82.1%).
- The [c.1408A; c.1210-12T[9]; c.744-33GATT[6]] haplotype was exclusively linked to mutant alleles, including F508del.
Conclusions:
- The studied polymorphisms (c.1408A>G, c.1210-12T(5_9), c.744-33GATT(6_8)) show potential for carrier detection in Iranian families with a history of CF.
- These genetic markers can contribute to more effective prenatal diagnosis strategies for cystic fibrosis in the Iranian population.


